Institutional development · Research, innovation and assessment · United States
NIH grant funds University of Michigan test of antibodies crossing brain's barrier
The University of Michigan has received National Institutes of Health funding to test whether an antibody treatment given intravenously can pass the brain's protective barrier to treat Alzheimer's disease.
Why it matters: University of Michigan researchers will use the NIH grant to test whether IV-delivered antibodies can reach the brain in Alzheimer's treatment.
The University of Michigan said a grant from the National Institutes of Health (NIH), the US federal medical research agency, will fund research at the university.
According to the university, the research will test the theory that an antibody treatment delivered intravenously can cross the brain's protective barrier.
The university described that barrier as one of the largest obstacles to treating Alzheimer's disease.
Editor’s view
Scott James, Research and Innovation Editor
University of Michigan researchers now have NIH funding to test whether intravenously delivered antibodies can cross the brain's protective barrier, which the university calls one of the biggest hurdles in Alzheimer's treatment.
